<?xml version="1.0" encoding="UTF-8"?>
<FlexiPage xmlns="http://soap.sforce.com/2006/04/metadata">
    <flexiPageRegions>
        <itemInstances>
            <componentInstance>
                <componentInstanceProperties>
                    <name>collapsed</name>
                    <value>false</value>
                </componentInstanceProperties>
                <componentInstanceProperties>
                    <name>enableActionsConfiguration</name>
                    <value>false</value>
                </componentInstanceProperties>
                <componentInstanceProperties>
                    <name>enableActionsInNative</name>
                    <value>false</value>
                </componentInstanceProperties>
                <componentInstanceProperties>
                    <name>hideChatterActions</name>
                    <value>false</value>
                </componentInstanceProperties>
                <componentInstanceProperties>
                    <name>numVisibleActions</name>
                    <value>3</value>
                </componentInstanceProperties>
                <componentName>force:highlightsPanel</componentName>
                <identifier>force_highlightsPanel</identifier>
            </componentInstance>
        </itemInstances>
        <mode>Replace</mode>
        <name>header</name>
        <type>Region</type>
    </flexiPageRegions>
    <flexiPageRegions>
        <itemInstances>
            <componentInstance>
                <componentName>force:detailPanel</componentName>
                <identifier>force_detailPanel</identifier>
            </componentInstance>
        </itemInstances>
        <itemInstances>
            <componentInstance>
                <componentInstanceProperties>
                    <name>parentFieldApiName</name>
                    <value>PJN_Assistance_Program__c.Id</value>
                </componentInstanceProperties>
                <componentInstanceProperties>
                    <name>relatedListApiName</name>
                    <value>Histories</value>
                </componentInstanceProperties>
                <componentInstanceProperties>
                    <name>relatedListComponentOverride</name>
                    <value>NONE</value>
                </componentInstanceProperties>
                <componentInstanceProperties>
                    <name>rowsToDisplay</name>
                    <value>10</value>
                </componentInstanceProperties>
                <componentInstanceProperties>
                    <name>showActionBar</name>
                    <value>true</value>
                </componentInstanceProperties>
                <componentName>force:relatedListSingleContainer</componentName>
                <identifier>force_relatedListSingleContainer</identifier>
            </componentInstance>
        </itemInstances>
        <mode>Replace</mode>
        <name>main</name>
        <type>Region</type>
    </flexiPageRegions>
    <flexiPageRegions>
        <itemInstances>
            <componentInstance>
                <componentInstanceProperties>
                    <name>decorate</name>
                    <value>true</value>
                </componentInstanceProperties>
                <componentInstanceProperties>
                    <name>richTextValue</name>
                    <value>&lt;p&gt;&lt;b style=&quot;font-size: 14px;&quot;&gt;PAP Eligibility Criteria&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Patient must have been prescribed EVKEEZA for an FDA-approved indication as confirmed by ICD-10 code and diagnosis confirmation of the Start or CTT Form.&amp;nbsp;&lt;/span&gt;&lt;ul&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;May be confirmed verbally on recorded line if not indicated on Form.&amp;nbsp;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Patient must be a resident of the United States or its territories or possessions.&amp;nbsp;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Patient must be treated by an HCP licensed in the United States or one of the US territories or possessions.&amp;nbsp;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Patient must be uninsured, functionally uninsured, or meet the Medicare Part B PAP criteria. Insurance coverage status must be verified through a completed benefit investigation or a documented current coverage policy.&amp;nbsp;&lt;/span&gt;&lt;ul&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Uninsured – patient does not have health insurance at all or has health insurance that does not include drug coverage&amp;nbsp;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Functionally Uninsured – patient has health insurance (commercial or gov’t insured) providing drug coverage, but it does not cover EVKEEZA for the patient for one of the following reasons:&amp;nbsp;&lt;/span&gt;&lt;ul&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Prior authorization and all appeals exhausted&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Exceeds annual or lifetime maximum&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;If submitted by an office that is not able to or has not pursued coverage through the pharmacy benefit as an alternate option, then the case will be triaged to Orsini SP for coverage review prior to deeming functionally uninsured. Commercial patients may qualify under criteria listed in 4.2.4.3 while pharmacy coverage is explored.&amp;nbsp;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Commercially Insured Patient with Pending PA Appeal – Patient has a PA that has been denied and an appeal has been submitted to the payer but the patient is experiencing a delay in receiving appeal decision for at least five business days.&amp;nbsp;&lt;/span&gt;&lt;ul&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Patient will be approved while the PA appeal is in process and may receive up to two 1-month supplies of EVKEEZA. Confirmation of in-process status will be completed before 2nd month supply provided.&amp;nbsp;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Patient will be granted an additional 30 days supplyif it is confirmed that all follow up and information required by the payer to make a determination has been supplied by the HCP and/or patient. Total of 3 month supply may not be exceeded.&amp;nbsp;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Medicare Part B Patients – Patient must have Part B only with no supplemental insurance coverage and no Part D plan.&amp;nbsp;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;A completed enrollment form must be on file and both patient signatures Authorization to Use/Disclose Health Information and Patient Certification must be on file.&amp;nbsp;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Total household annual gross income (“AGI”) must be less than or equal to the greater of: (a) $100,000, or (b) 500% of Federal Poverty Level.&amp;nbsp;&lt;/span&gt;&lt;/li&gt;&lt;li&gt;&lt;span style=&quot;font-size: 12px;&quot;&gt;Patient assistance is not available to patients where reimbursement for drugs and biologics is included in a diagnosis related group (DRG), case rate, ambulatory payment classification (APC), per-diem rate or other prospective/packaged payment unless the patient’s HCP submits documentation that the patient’s insurer specifically denied coverage for EVKEEZA and has notified the HCP that the insurer will reduce its reimbursement to the HCP if the denied product is used. Assistance is not provided when the non-coverage reason is the HCP is out of network with the patient’s insurance plan.&amp;nbsp;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;br&gt;&lt;/p&gt;&lt;p&gt;&lt;i style=&quot;font-size: 12px;&quot;&gt;For further details, reference SOP 1.05 Evinacumab Patient Assistance Program&lt;/i&gt;&lt;/p&gt;</value>
                </componentInstanceProperties>
                <componentName>flexipage:richText</componentName>
                <identifier>flexipage_richText</identifier>
            </componentInstance>
        </itemInstances>
        <itemInstances>
            <componentInstance>
                <componentInstanceProperties>
                    <name>parentFieldApiName</name>
                    <value>PJN_Assistance_Program__c.Id</value>
                </componentInstanceProperties>
                <componentInstanceProperties>
                    <name>relatedListApiName</name>
                    <value>AttachedContentDocuments</value>
                </componentInstanceProperties>
                <componentInstanceProperties>
                    <name>relatedListComponentOverride</name>
                    <value>NONE</value>
                </componentInstanceProperties>
                <componentInstanceProperties>
                    <name>rowsToDisplay</name>
                    <value>10</value>
                </componentInstanceProperties>
                <componentInstanceProperties>
                    <name>showActionBar</name>
                    <value>true</value>
                </componentInstanceProperties>
                <componentName>force:relatedListSingleContainer</componentName>
                <identifier>force_relatedListSingleContainer2</identifier>
            </componentInstance>
        </itemInstances>
        <mode>Replace</mode>
        <name>sidebar</name>
        <type>Region</type>
    </flexiPageRegions>
    <masterLabel>MVN - PAP Record Page</masterLabel>
    <parentFlexiPage>flexipage__default_rec_L</parentFlexiPage>
    <sobjectType>PJN_Assistance_Program__c</sobjectType>
    <template>
        <name>flexipage:recordHomeTemplateDesktop</name>
    </template>
    <type>RecordPage</type>
</FlexiPage>
